Skip to content
healthcare.dev

DEXTROAMPHETAMINE SULFATE

NDC 13107-035, DEXTROAMPHETAMINE SULFATE, tablet, from Aurolife Pharma, LLC.

Product NDC
13107-035
Status
Listed
Labeler
Aurolife Pharma, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202893
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/13107-035 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEXTROAMPHETAMINE SULFATE5 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
13107-035-0113107003501100 TABLET in 1 BOTTLE (13107-035-01)
13107-035-501310700355050 TABLET in 1 BOTTLE (13107-035-50)
13107-035-99131070035991000 TABLET in 1 BOTTLE (13107-035-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/24163442-dd03-4066-a6ed-eb7e292b700b
  • NADAC price for package 13107003501

    GET /v1/drugs/nadac/13107003501

Use it

Look up 13107-035 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/13107-035 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 13107-035. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.